Quest CEO Promises 'More and More' Esoteric, Genetic Tests to Emerge

CEO Mohapatra said Quest will be doing "more and more" high-margin esoteric and gene-based testing "whether for personalized medicine" or to "improve specificity and sensitivity almost all aspects of cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.